PARADIGM BIOPHARMACEUTICALS LIMITED..

The current price of PAR is 0.285 AUD — it hasn't changed in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PARADIGM BIOPHARMACEUTICALS LIMITED.. stocks are traded under the ticker PAR.

PARADIGM BIOPHARMACEUTICALS LIMITED.. is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.

PAR stock is 7.14% volatile and has beta coefficient of 0.18. Check out the list of the most volatile stocks — is PARADIGM BIOPHARMACEUTICALS LIMITED.. there?

Yes, you can track PARADIGM BIOPHARMACEUTICALS LIMITED.. financials in yearly and quarterly reports right on TradingView.

PAR stock has risen by 1.79% compared to the previous week, the month change is a 20.83% fall, over the last year PARADIGM BIOPHARMACEUTICALS LIMITED.. has showed a 71.83% decrease.

Today PARADIGM BIOPHARMACEUTICALS LIMITED.. has the market capitalization of ‪88.33 M‬, it has decreased by 11.59% over the last week.

No, PAR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, PAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PARADIGM BIOPHARMACEUTICALS LIMITED.. stock right from TradingView charts — choose your broker and connect to your account.

PAR reached its all-time high on Feb 5, 2020 with the price of 4.345 AUD, and its all-time low was 0.215 AUD and was reached on Jun 16, 2017.
See other stocks reaching their highest and lowest prices.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PARADIGM BIOPHARMACEUTICALS LIMITED.. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PARADIGM BIOPHARMACEUTICALS LIMITED.. stock shows the strong sell signal. See more of PARADIGM BIOPHARMACEUTICALS LIMITED.. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PARADIGM BIOPHARMACEUTICALS LIMITED.. EBITDA is ‪−76.66 M‬ AUD, and current EBITDA margin is ‪−126.31 K‬%. See more stats in PARADIGM BIOPHARMACEUTICALS LIMITED.. financial statements.